TME Clinical Trials

717 recruitingLast updated: July 25, 2026

There are 717 actively recruiting tme clinical trials across 57 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4, Early Phase 1. Top locations include Tianjin, Tianjin Municipality, China, Toronto, Ontario, Canada, New York, New York, United States. Updated daily from ClinicalTrials.gov.


TME Trials at a Glance

717 actively recruiting trials for tme are listed on ClinicalTrialsFinder across 6 cities in 57 countries. The largest study group is Not Applicable with 319 trials, with the heaviest enrollment activity in Tianjin, Toronto, and New York. Lead sponsors running tme studies include Institute of Hematology & Blood Diseases Hospital, China, Centre for Addiction and Mental Health, and Shanghai Juncell Therapeutics.

Treatments under study

About TME Clinical Trials

Looking for clinical trials for TME? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new TME trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about TME clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 717 trials

Recruiting
Phase 1

Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer

First-line TreatmentMetastatic Colorectal Cancer (CRC)Phase 1+4 more
M.D. Anderson Cancer Center41 enrolled1 locationNCT07500298
Recruiting
Not Applicable

Coaching as an Adjunct to Ketamine Therapy for Treatment-Resistant Depression

Treatment Resistant Depression (TRD)
Massachusetts General Hospital20 enrolled2 locationsNCT07563868
Recruiting
Not Applicable

Virtual Reality-Enhanced Behavioral Activation for Older Adults With Depression

Depression - Major Depressive DisorderOlder Adults (65 Years and Older)Behavioral Activation Treatment+1 more
Stanford University30 enrolled1 locationNCT07188623
Recruiting

Sequential Therapies After Osteoanabolic Treatment

Osteoporosis, Postmenopausal
424 General Military Hospital150 enrolled8 locationsNCT06164795
Recruiting
Phase 1

Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis Risk in Postmenopausal Females

postmenopausal osteoporosisMenopauseGut Microbiome
University of Connecticut159 enrolled1 locationNCT07365514
Recruiting
Phase 2

Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery

Neoadjuvant TreatmentThyroid Cancer
M.D. Anderson Cancer Center45 enrolled3 locationsNCT06959511
Recruiting
Phase 2

Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure

Unresectable or Metastatic Hepatocellular CarcinomaChild-Pugh A Hepatocellular CarcinomaFailure of First-Line Treatment That Included an Approved Anti PD-(L)1 Compound
CatalYm GmbH104 enrolled14 locationsNCT07219459
Recruiting
Not Applicable

Unravelling the Impact of Radiofrecuency in Liver Surgery: the Key to Decrease Local Recurrence?

Liver CancerCancer, Treatment-Related
Hospital del Mar720 enrolled1 locationNCT05492136
Recruiting
Phase 2

Testing a Functional Precision Medicine Approach to Select Chemotherapy for Metastatic Colorectal Cancer (COSENSE-1)

Metastatic Colorectal CancerFirst-line TreatmentOrganoids+3 more
St. Olavs Hospital148 enrolled1 locationNCT06907342
Recruiting

Biorepository in Participants Who Undergo OTC for Gonadotoxic Therapy

InfertilityAcute Ovarian FailureEarly Menopause And Infertility In Females After Treatment For Childhood Cancer
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)100 enrolled1 locationNCT05440617
Recruiting

Natural History of Depression, Bipolar Disorder and Suicide Risk

Molecular Mechanisms of Pharmacological ActionDepressive SymptomsSuicide+18 more
National Institute of Mental Health (NIMH)500 enrolled1 locationNCT06462196
Recruiting
Not Applicable

Comparative Evaluation of the Effects of Calcium Hydroxide and BIO-C Temp Medicaments on Postoperative Pain in Patients Undergoing Endodontic Treatment: a Clinical Study

Postoperative PainCalcium HydroxideRoot Canal Retreatment+1 more
Ankara University60 enrolled2 locationsNCT07396688
Recruiting

Reducing Parental Substance Use and Enhancing Family Resilience Among Rural Families Through Ohio START

Rural HealthSubstance Use Disorder (SUD)Child Maltreatment+3 more
Ohio State University400 enrolled1 locationNCT07278427
Recruiting
Not Applicable

Middle Meningeal Artery Embolization for Patients With Chronic Subdural Hematoma

Chronic Subdural HematomaEndovascular Treatment
Kazutaka Uchida600 enrolled1 locationNCT06772740
Recruiting

Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up

EpilepsyEpilepsy (Treatment Refractory)
Epiminder America, Inc.210 enrolled16 locationsNCT07110454
Recruiting
Phase 2

ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response

Major Depressive Disorder (MDD)Depressive Disorder, Treatment-Resistant
ACADIA Pharmaceuticals Inc.153 enrolled23 locationsNCT07284667
Recruiting
Not Applicable

Diagnosing Epilepsy To EffeCT Change

EpilepsyEpilepsy (Treatment Refractory)
Epiminder America, Inc.210 enrolled19 locationsNCT07110337
Recruiting
Not Applicable

Analysis of Safety and Tissue Interaction of Injectable Biosmulators

This Study Aims to Evaluate the Safety Profile and Tissue Changes After Biostimulatory Treatments to the Face in Healthy Volunteers
Universitätsklinikum Hamburg-Eppendorf90 enrolled1 locationNCT06993558
Recruiting
Not Applicable

Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial

StrokeICAD - Intracranial Atherosclerotic DiseaseICAS - Intracranial Atherosclerosis+3 more
Beijing Tiantan Hospital358 enrolled18 locationsNCT04948749
Recruiting
Phase 1

To Test a New Drug (LCFA-01) for Safety and PK in Healthy Adults for Bacterial Vaginosis Infection.

Bacterial Vaginosis Treatment
Massachusetts General Hospital30 enrolled1 locationNCT07514416